Morphometric Evaluation of the Facial and Vestibulocochlear Nerves Using MR Imaging in Patients with Menière Disease

References

1. 1.↵
   1. Semaan MT,
   2. Alagramam KN,
   3. Megerian CA

   . The basic science of Meniere’s disease and endolymphatic hydrops. Curr Opin Otolaryngol Head Neck Surg 2005;13:301–07 doi:10.1097/01.moo.0000186335.44206.1c pmid:16160525

   CrossRefPubMed
2. 2.↵
   1. Plontke SK,
   2. Gürkov R

   . Menière’s disease [in German]. Laryngorhinootologie 2015;94:530–54 doi:10.1055/s-0035-1555808 pmid:26243634

   CrossRefPubMed
3. 3.↵
   1. Berlinger NT

   . Meniere’s disease: new concepts, new treatments. Minn Med 2011;94:33–36 pmid:22413647

   PubMed
4. 4.↵
   1. Yang CH,
   2. Yang MY,
   3. Hwang CF, et al

   . Functional and molecular markers for hearing loss and vertigo attacks in Meniere’s disease. Int J Mol Sci 2023;24:2504 doi:10.3390/ijms24032504 pmid:36768827

   CrossRefPubMed
5. 5.↵
   1. Tsuji K,
   2. Velazquez-Villasenor L,
   3. Rauch SD, et al

   . Temporal bone studies of the human peripheral vestibular system. Meniere’s disease. Ann Otol Rhinol Laryngol Suppl 2000;181:26–31 doi:10.1177/00034894001090s505 pmid:10821232

   CrossRefPubMed
6. 6.↵
   1. Kariya S,
   2. Cureoglu S,
   3. Fukushima H, et al

   . Histopathologic changes of contralateral human temporal bone in unilateral Meniere’s disease. Otol Neurotol 2007;28:1063–68 doi:10.1097/MAO.0b013e31815a8433 pmid:18043432

   CrossRefPubMed
7. 7.↵
   1. Megerian CA

   . Diameter of the cochlear nerve in endolymphatic hydrops: implications for the etiology of hearing loss in Meniere’s disease. Laryngoscope 2005;115:1525–35 doi:10.1097/01.mlg.0000167804.82950.9e pmid:16148690

   CrossRefPubMed
8. 8.↵
   1. Arweiler DJ,
   2. Jahnke K,
   3. Grosse-Wilde H

   . Meniere disease as an autosome dominant hereditary disease [in German]. Laryngorhinootologie 1995;74:512–15 doi:10.1055/s-2007-997791 pmid:7575905

   CrossRefPubMed
9. 9.↵
   1. Paparella MM,
   2. de Sousa LC,
   3. Mancini F

   . Meniere’s syndrome and otitis media. Laryngoscope 1983;93:1408–15 pmid:6633111

   CrossRefPubMedWeb of Science
10. 10.↵
    1. Arenberg IK,
    2. Lemke C,
    3. Shambaugh GE Jr.

    . Viral theory for Ménière’s disease and endolymphatic hydrops: overview and new therapeutic options for viral labyrinthitis. Ann N Y Acad Sci 1997;830:306–13 doi:10.1111/j.1749-6632.1997.tb51901.x pmid:9616689

    CrossRefPubMed
11. 11.↵
    1. Vasama JP,
    2. Linthicum FH Jr.

    . Meniere’s disease and endolymphatic hydrops without Meniere’s symptoms: temporal bone histopathology. Acta Otolaryngol 1999;119:297–301 doi:10.1080/00016489950181279 pmid:10380731

    CrossRefPubMed
12. 12.↵
    1. Gurkov R,
    2. Berman A,
    3. Dietrich O, et al

    . MR volumetric assessment of endolymphatic hydrops. Eur Radiol 2015;25:585–95 doi:10.1007/s00330-014-3414-4 pmid:25319347

    CrossRefPubMed
13. 13.↵
    1. Pyykko I,
    2. Nakashima T,
    3. Yoshida T, et al

    . Meniere’s disease: a reappraisal supported by a variable latency of symptoms and the MRI visualisation of endolymphatic hydrops. BMJ Open 2013;3:e001555 doi:10.1136/bmjopen-2012-001555

    Abstract/FREE Full Text
14. 14.↵
    1. Gurkov R,
    2. Flatz W,
    3. Ertl-Wagner B, et al

    . Endolymphatic hydrops in the horizontal semicircular canal: a morphologic correlate for canal paresis in Meniere’s disease. Laryngoscope 2013;123:503–06 doi:10.1002/lary.23395 pmid:22865507

    CrossRefPubMed
15. 15.↵
    1. Bernaerts A,
    2. Vanspauwen R,
    3. Blaivie C, et al

    . The value of four stage vestibular hydrops grading and asymmetric perilymphatic enhancement in the diagnosis of Menière’s disease on MRI. Neuroradiology 2019;61:421–29 doi:10.1007/s00234-019-02155-7 pmid:30719545

    CrossRefPubMed
16. 16.↵
    1. Paškonienė A,
    2. Baltagalvienė R,
    3. Lengvenis G, et al

    . The importance of the temporal bone 3T MR imaging in the diagnosis of Menière’s disease. Otol Neurotol 2020;41:235–41 doi:10.1097/MAO.0000000000002471 pmid:31743294

    CrossRefPubMed
17. 17.↵
    1. Deng W,
    2. Lin X,
    3. Su Y, et al

    . Comparison between 3D-FLAIR and 3D-real IR MRI sequences with visual classification method in the imaging of endolymphatic hydrops in Meniere’s disease. Am J Otolaryngol 2022;43:103557 doi:10.1016/j.amjoto.2022.103557 pmid:35994892

    CrossRefPubMed
18. 18.↵
    1. Bernaerts A,
    2. Janssen N,
    3. Wuyts FL, et al

    . Comparison between 3D SPACE FLAIR and 3D TSE FLAIR in Menière’s disease. Neuroradiology 2022;64:1011–20 doi:10.1007/s00234-022-02913-0 pmid:35149883

    CrossRefPubMed
19. 19.↵
    1. Jaryszak EM,
    2. Patel NA,
    3. Camp M, et al

    . Cochlear nerve diameter in normal hearing ears using high-resolution magnetic resonance imaging. Laryngoscope 2009;119:2042–45 doi:10.1002/lary.20516 pmid:19650137

    CrossRefPubMed
20. 20.↵
    1. Nakamichi R,
    2. Yamazaki M,
    3. Ikeda M, et al

    . Establishing normal diameter range of the cochlear and facial nerves with 3D-CISS at 3T. Magn Reson Med Sci 2013;12:241–47 doi:10.2463/mrms.2013-0004

    CrossRefPubMed
21. 21.↵
    1. Kang WS,
    2. Hyun SM,
    3. Lim HK, et al

    . Normative diameters and effects of aging on the cochlear and facial nerves in normal-hearing Korean ears using 3.0-Tesla magnetic resonance imaging. Laryngoscope 2012;122:1109–14 doi:10.1002/lary.23184 pmid:22374919

    CrossRefPubMed
22. 22.↵
    1. Henneberger A,
    2. Ertl-Wagner B,
    3. Reiser M, et al

    . Morphometric evaluation of facial and vestibulocochlear nerves using magnetic resonance imaging: comparison of Meniere’s disease ears with normal hearing ears. Eur Arch Otorhinolaryngol 2017;274:3029–39 doi:10.1007/s00405-017-4616-6 pmid:28584970

    CrossRefPubMed
23. 23.↵
    1. Peng L,
    2. Xiao Y,
    3. Liu L, et al

    . Evaluation of cochlear nerve diameter and cross-sectional area in ANSD patients by 3.0-Tesla MRI. Acta Otolaryngol 2016;136:792–99 doi:10.3109/00016489.2016.1159329 pmid:27003148

    CrossRefPubMed
24. 24.↵
    1. Tyrrell JS,
    2. Whinney DJ,
    3. Ukoumunne OC, et al

    . Prevalence, associated factors, and comorbid conditions for Ménière’s disease. Ear Hear 2014;35:e162–69 doi:10.1097/AUD.0000000000000041 pmid:24732693

    CrossRefPubMed
25. 25.↵
    1. Liu Y,
    2. Jia H,
    3. Shi J, et al

    . Endolymphatic hydrops detected by 3-dimensional fluid-attenuated inversion recovery MRI following intratympanic injection of gadolinium in the asymptomatic contralateral ears of patients with unilateral Ménière’s disease. Med Sci Monit 2015;21:701–07 doi:10.12659/MSM.892383 pmid:25742875

    CrossRefPubMed
26. 26.↵
    1. Ark ED,
    2. Boya MN,
    3. Shah A, et al

    . Four-hour-delayed gadolinium 3D REAL IR and SPACE FLAIR MRI correlated to Meniere disease histology. Ear Nose Throat J 2024 Jun 13 [Epub ahead of print] doi:10.1177/01455613241261461 pmid:38872311

    CrossRefPubMed
27. 27.
    Committee on Hearing and Equilibrium Guidelines for the diagnosis and evaluation of therapy in Meniere’s disease: American Academy of Otolaryngology-Head and Neck Foundation, Inc. Otolaryngol-Head and Neck Surg 1995;113:181–85 doi:10.1016/S0194-5998(95)70102-8 pmid:7675476

    CrossRefPubMedWeb of Science
28. 28.↵
    1. Gurkov R,
    2. Kantner C,
    3. Strupp M, et al

    . Endolymphatic hydrops in patients with vestibular migraine and auditory symptoms. Eur Arch Otorhinolaryngol 2014;271:2661–67 doi:10.1007/s00405-013-2751-2 pmid:24121780

    CrossRefPubMed
29. 29.↵
    1. Gurkov R,
    2. Pyyko I,
    3. Zou J, et al

    . What is Meniere’s disease? A contemporary re-evaluation of endolymphatic hydrops. J Neurol 2016;263(Suppl 1):S71–81 doi:10.1007/s00415-015-7930-1 pmid:27083887

    CrossRefPubMed
30. 30.↵
    1. Nakashima T,
    2. Pyykko I,
    3. Arroll MA, et al

    . Meniere’s disease. Nat Rev Dis Primers 2016;2:16028 doi:10.1038/nrdp.2016.28 pmid:27170253

    CrossRefPubMed
31. 31.↵
    1. Shi S,
    2. Guo P,
    3. Li W, et al

    . Clinical features and endolymphatic hydrops in patients with MRI evidence of hydrops. Ann Otol Rhinol Laryngol 2019;128:286–92 doi:10.1177/0003489418819551 pmid:30556402

    CrossRefPubMed
32. 32.↵
    1. Jerin C,
    2. Krause E,
    3. Ertl-Wagner B, et al

    . Longitudinal assessment of endolymphatic hydrops with contrast-enhanced magnetic resonance imaging of the labyrinth. Otol Neurotol 2014;35:880–83 doi:10.1097/MAO.0000000000000393 pmid:24770407

    CrossRefPubMed
33. 33.↵
    1. Nakashima T,
    2. Naganawa S,
    3. Katayama N, et al

    . Clinical significance of endolymphatic imaging after intratympanic gadolinium injection. Acta Otolaryngol Suppl 2009(560):9–14 doi:10.1080/00016480902729801 pmid:19221901

    CrossRefPubMed
34. 34.↵
    1. Nakashima T,
    2. Naganawa S,
    3. Sugiura M, et al

    . Visualization of endolymphatic hydrops in patients with Meniere’s disease. Laryngoscope 2007;117:415–20 doi:10.1097/MLG.0b013e31802c300c pmid:17279053

    CrossRefPubMedWeb of Science
35. 35.↵
    1. Barath K,
    2. Schuknecht B,
    3. Naldi AM, et al

    . Detection and grading of endolymphatic hydrops in Meniere disease using MR imaging. AJNR Am J Neuroradiol 2014;35:1387–92 doi:10.3174/ajnr.A3856 pmid:24524921

    Abstract/FREE Full Text
36. 36.↵
    1. Neri G,
    2. Tartaro A,
    3. Neri L

    . MRI with intratympanic gadolinium: comparison between otoneurological and radiological investigation in Menière’s disease. Front Surg 2021;8:672284 doi:10.3389/fsurg.2021.672284 pmid:34169089

    CrossRefPubMed
37. 37.↵
    1. Diorflar S,
    2. Guigou C,
    3. Daguet E, et al

    . Confrontation of endolymphatic hydrops diagnosis on 3-Tesla MRI to clinical and audiovestibular findings in Meniere’s disease. Front Neurol 2023;14:1105461 doi:10.3389/fneur.2023.1105461 pmid:36779070

    CrossRefPubMed
38. 38.↵
    1. Paparella MM,
    2. Djalilian HR

    . Etiology, pathophysiology of symptoms, and pathogenesis of Meniere’s disease. Otolaryngol Clin North Am 2002;35:529–45, vi doi:10.1016/s0030-6665(02)00019-1 pmid:12486838

    CrossRefPubMedWeb of Science
39. 39.↵
    1. Liu Y,
    2. Yang J,
    3. Duan M

    . Current status on researches of Meniere’s disease: a review. Acta Otolaryngol 2020;140:808–12 doi:10.1080/00016489.2020.1776385 pmid:32564698

    CrossRefPubMed
40. 40.↵
    1. Arbusow V,
    2. Derfuss T,
    3. Held K, et al

    . Latency of herpes simplex virus type-1 in human geniculate and vestibular ganglia is associated with infiltration of CD8+ T cells. J Med Virol 2010;82:1917–20 doi:10.1002/jmv.21904 pmid:20872719

    CrossRefPubMed
41. 41.↵
    1. Xu W,
    2. Li X,
    3. Song Y, et al

    . Ménière’s disease and allergy: epidemiology, pathogenesis, and therapy. Clin Exp Med 2023;23:3361–71 doi:10.1007/s10238-023-01192-0 pmid:37743423

    CrossRefPubMed
42. 42.↵
    1. Xie S,
    2. Zhang R,
    3. Tang Y, et al

    . Exploring causal correlations between inflammatory cytokines and Ménière’s disease: a Mendelian randomization. Front Immunol 2024;15:1373723 doi:10.3389/fimmu.2024.1373723 pmid:38742115

    CrossRefPubMed
43. 43.↵
    1. Frejo L,
    2. Lopez-Escamez JA

    . Cytokines and inflammation in Meniere disease. Clin Exp Otorhinolaryngol 2022;15:49–59 doi:10.21053/ceo.2021.00920 pmid:35124944

    CrossRefPubMed
44. 44.↵
    1. Klockars T,
    2. Kentala E

    . Inheritance of Meniere’s disease in the Finnish population. Arch Otolaryngol Head Neck Surg 2007;133:73–77 doi:10.1001/archotol.133.1.73 pmid:17224529

    CrossRefPubMed
45. 45.↵
    1. Mohseni-Dargah M,
    2. Falahati Z,
    3. Pastras C, et al

    . Meniere’s disease: pathogenesis, treatments, and emerging approaches for an idiopathic bioenvironmental disorder. Environ Res 2023;238:116972 doi:10.1016/j.envres.2023.116972 pmid:37648189

    CrossRefPubMed
46. 46.↵
    1. Hess A,
    2. Bloch W,
    3. Huverstuhl J, et al

    . Expression of inducible nitric oxide synthase (iNOS/NOS II) in the cochlea of guinea pigs after intratympanical endotoxin-treatment. Brain Res 1999;830:113–22 doi:10.1016/s0006-8993(99)01433-x pmid:10350565

    CrossRefPubMed
47. 47.↵
    1. Kong WJ,
    2. Ren T,
    3. Nuttall AL

    . Electrophysiological and morphological evaluation of the acute ototoxicity of sodium nitroprusside. Hear Res 1996;99:22–30 doi:10.1016/s0378-5955(96)00076-7 pmid:8970810

    CrossRefPubMedWeb of Science
48. 48.↵
    1. Ishiyama G,
    2. Lopez IA,
    3. Sepahdari AR, et al

    . Meniere’s disease: histopathology, cytochemistry, and imaging. Ann N Y Acad Sci 2015;1343:49–57 doi:10.1111/nyas.12699 pmid:25766597

    CrossRefPubMed
49. 49.↵
    1. Lopez-Escamez JA,
    2. Liu Y

    . Epidemiology and genetics of Meniere’s disease. Curr Opin Neurol 2024;37:88–94 doi:10.1097/WCO.0000000000001227 pmid:37865853

    CrossRefPubMed
50. 50.↵
    1. Yuan X,
    2. Li X,
    3. Xu Y, et al

    . Microstructural changes of the vestibulocochlear nerve in patients with Ménière’s disease using diffusion tensor imaging. Front Neurol 2022;13:915826 doi:10.3389/fneur.2022.915826 pmid:36226092

    CrossRefPubMed